Zhejiang CONBA Pharmaceutical Co Ltd (600572) — Net Asset Quality Index
Zhejiang CONBA Pharmaceutical Co Ltd (600572) has a Net Asset Quality Index of 72.1% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥10.22 Billion minus total liabilities of CN¥2.85 Billion yields net assets of CN¥7.37 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check how resilient are Zhejiang CONBA Pharmaceutical Co Ltd's assets to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Zhejiang CONBA Pharmaceutical Co Ltd Net Asset Quality Index Over Time (2001–2025)
This chart shows how Zhejiang CONBA Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 25 annual periods from 2001 to 2025. As of March 2026, the index stands at 72.1%, representing net assets of CN¥7.37 Billion against total assets of CN¥10.22 Billion CNY. See Zhejiang CONBA Pharmaceutical Co Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Zhejiang CONBA Pharmaceutical Co Ltd (2001–2025)
The table below presents the year-by-year Net Asset Quality Index for Zhejiang CONBA Pharmaceutical Co Ltd from 2001 to 2025, covering 25 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market value of Zhejiang CONBA Pharmaceutical Co Ltd.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 71.6% | CN¥7.15 Billion | CN¥9.98 Billion | CN¥2.83 Billion | ▲ +1.8 pp |
| 2024 | 69.8% | CN¥6.91 Billion | CN¥9.90 Billion | CN¥2.99 Billion | ▲ +4.4 pp |
| 2023 | 65.4% | CN¥7.35 Billion | CN¥11.24 Billion | CN¥3.89 Billion | ▼ -1.6 pp |
| 2022 | 67.0% | CN¥7.32 Billion | CN¥10.93 Billion | CN¥3.61 Billion | ▼ -1.5 pp |
| 2021 | 68.5% | CN¥7.39 Billion | CN¥10.79 Billion | CN¥3.40 Billion | ▲ +10.8 pp |
| 2020 | 57.7% | CN¥5.35 Billion | CN¥9.28 Billion | CN¥3.93 Billion | ▲ +7.5 pp |
| 2019 | 50.1% | CN¥4.94 Billion | CN¥9.86 Billion | CN¥4.92 Billion | ▼ -3.9 pp |
| 2018 | 54.1% | CN¥5.79 Billion | CN¥10.71 Billion | CN¥4.92 Billion | ▼ -8.0 pp |
| 2017 | 62.0% | CN¥5.84 Billion | CN¥9.42 Billion | CN¥3.58 Billion | ▲ +9.2 pp |
| 2016 | 52.8% | CN¥4.49 Billion | CN¥8.50 Billion | CN¥4.01 Billion | ▲ +5.1 pp |
| 2015 | 47.7% | CN¥4.57 Billion | CN¥9.57 Billion | CN¥5.00 Billion | ▼ -5.8 pp |
| 2014 | 53.5% | CN¥3.37 Billion | CN¥6.30 Billion | CN¥2.93 Billion | ▼ -4.7 pp |
| 2013 | 58.2% | CN¥2.59 Billion | CN¥4.45 Billion | CN¥1.86 Billion | ▲ +4.4 pp |
| 2012 | 53.8% | CN¥2.44 Billion | CN¥4.54 Billion | CN¥2.10 Billion | ▼ -0.7 pp |
| 2011 | 54.5% | CN¥1.61 Billion | CN¥2.96 Billion | CN¥1.35 Billion | ▼ -15.2 pp |
| 2010 | 69.7% | CN¥1.72 Billion | CN¥2.46 Billion | CN¥747.34 Million | ▲ +10.2 pp |
| 2009 | 59.5% | CN¥1.15 Billion | CN¥1.93 Billion | CN¥780.76 Million | ▲ +0.9 pp |
| 2008 | 58.6% | CN¥919.66 Million | CN¥1.57 Billion | CN¥649.60 Million | ▲ +3.4 pp |
| 2007 | 55.2% | CN¥854.74 Million | CN¥1.55 Billion | CN¥693.32 Million | ▲ +5.2 pp |
| 2006 | 50.0% | CN¥627.66 Million | CN¥1.26 Billion | CN¥628.20 Million | ▼ -1.5 pp |
| 2005 | 51.5% | CN¥595.08 Million | CN¥1.16 Billion | CN¥560.55 Million | ▼ -6.1 pp |
| 2004 | 57.6% | CN¥565.05 Million | CN¥981.41 Million | CN¥416.37 Million | ▲ +16.4 pp |
| 2003 | 41.2% | CN¥239.44 Million | CN¥581.65 Million | CN¥342.22 Million | ▼ -2.2 pp |
| 2002 | 43.4% | CN¥200.75 Million | CN¥462.63 Million | CN¥261.88 Million | ▲ +2.8 pp |
| 2001 | 40.6% | CN¥181.89 Million | CN¥447.63 Million | CN¥265.74 Million | — |